Purpose: To identify risks factors for retreatment post-laser in situ keratomeliusis (LASIK).
Materials & Methods: A retrospective chart review from December 2008 to September 2012 identified 1,402 patients (2,581 eyes) that underwent LASIK treatment for myopia with the Intralase™ FS, STAR S4 IR™ Excimer Laser, and WaveScan WaveFront™ technology. In this group, 83 patients were retreated.